November 08, 2025 17:13 ET | Source: Intellia Therapeutics, Inc. Deep, stable and durable reductions in kallikrein observed Among 32 patients…
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive long-term safety results from its EXTEND study, a…
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…
DUBAI, UAE, Oct. 27, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is listing Syndicate (SYND) to…
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed with no safety or tolerability issues observed, allowing…
The Cycling Federation of India (CFI) as the technical partner, oversaw event guidelines, rules, and regulatory compliance. The theme was…
October 13, 2025 21:22 ET | Source: Apollomics Inc. FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc.…
Daniil Kvyat returns to the wheel of the #63 LMDh alongside Grosjean and Mortara at Road AtlantaSant’Agata Bolognese, 7 October…
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…
Glendale, CA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- In an exciting turn of events, Happy Go Leafy announced that its…